Navigation Intervention for Colorectal Cancer

Massachusetts General Hospital, Boston, MA
Targeting 2 different conditionsHealth Insurance Navigation Tools ProgramN/ARecruitingResearch Sponsored by Massachusetts General Hospital

Study Summary

This trial assesses whether a navigation intervention called HINT can help colorectal cancer survivors with health insurance literacy and financial burden related to medical cost concerns.

Eligible Conditions
  • Colorectal Cancer
  • Health Insurance


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change from baseline health insurance literacy to 5-month follow-up
feasibility and acceptability of the health insurance navigation program

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Navigation InterventionExperimental Treatment1 Intervention
The intervention will be delivered via synchronous videoconferencing (real-time delivery and communication between the navigator and the participant) by a trained patient navigator and will consist of 5, 30-minute sessions delivered every week. The navigation intervention group will also receive an online or mailed copy of the health insurance resource guide.
Group II: Enhanced Usual CareActive Control1 Intervention
Enhanced usual care will consist of an online or mailed health insurance resource guide.

Find a site

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,833 Previous Clinical Trials
13,567,251 Total Patients Enrolled

Media Library

Health Insurance Navigation Program Clinical Trial Eligibility Overview. Trial Name: NCT05002608 — N/A
Colorectal Cancer Research Study Groups: Navigation Intervention, Enhanced Usual Care
Colorectal Cancer Clinical Trial 2023: Health Insurance Navigation Program Highlights & Side Effects. Trial Name: NCT05002608 — N/A
Health Insurance Navigation Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05002608 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment of participants still underway for this clinical trial?

"Affirmative, the information hosted on suggests that this medical experiment is actively recruiting patients. It was initially posted November 1st 2021 and most recently updated February 9th 2022. The study requires 80 participants from 2 separate sites to complete it."

Answered by AI

Does this research encompass persons aged 65+?

"This research has a participant eligibility criteria of those 18 years or older and no more than 65."

Answered by AI

Who fits the criteria for eligibility in this clinical trial?

"This study seeks 80 eligible candidates, aged 18-65 and possessing insurance, to participate. Furthermore, participants should have access to digital devices with WIFI capabilities as well as being between 12 and 24 months post-treatment for stages I-III colon or rectal cancer. Additionally, the individual must have had a medical appointment at MGH within two years prior."

Answered by AI

How many people are registering for this research study?

"Affirmative. Evidence available on attests to the fact that recruitment is ongoing for this medical research, first posted in November 1st 2021 and recently updated February 9th 2022. Two sites are enrolling 80 volunteers each."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What site did they apply to?
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
~0 spots leftby Oct 2023